MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

GSK2982772

CAS No. : 1622848-92-3

MCE 国际站：GSK2982772

产品活性：GSK2982772 是可口服的、有效的 ATP 竞争型的 RIP1 酶抑制剂，对人和猴子 RIP1 的 IC₅₀ 值分别为 16 nM 和 20 nM。

研究领域：Apoptosis

作用靶点：RIP kinase

In Vitro: GSK2982772 shows more than 1,000-fold selectivity for ERK5 over a panel of over 339 kinases at 10 µM. In stimulated cellular systems,GSK2982772 is also able to reduce spontaneous production of cytokines (IL-1β and IL-6) in a concentration-dependent fashion from ulcerative colitis explant tissue in overnight incubations. GSK2982772 produces a weak concentration dependent inhibition of hERG in human embryonic kidney (HEK-293) cells, with an estimated IC₅₀ of 195 µM, and also shows a weak activation of the human Pregnane X receptor (hPXR) with an EC₅₀ of 13 µM.

In Vivo: GSK2982772 is dosed orally 15 min prior to TNF and shows 68, 80, and 87% protection from temperature loss over 6 h, at doses of 3, 10, and 50 mg/kg, respectively. In the corresponding TNF/zVAD model, GSK2982772 shows 13, 63, and 93% protection from temperature loss over 3 h. GSK2982772 displays a good free fraction in blood in rats (4.2%), dogs (11%), cynomolgus monkeys (11%), and humans (7.4%). The inhibitor has a good pharmacokinetic profile across both rats and monkeys. GSK2982772 distributes into a range of tissues including the colon, liver, kidney, and heart at concentrations comparable to those of blood. However, GSK2982772 has low brain penetration in rat (4%) despite possessing good cell permeability (21×10^-6 cm/s).

相关产品：Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Apoptosis Compound Library | Immunology/Inflammation Compound Library | Kinase Inhibitor Library | NF-κB Signaling Compound Library | Clinical Compound Library | CNS-Penetrant Compound Library | Drug Repurposing Compound Library | Anti-COVID-19 Compound Library | Pyroptosis Compound Library | Orally Active Compound Library | Necrostatin-1 | GSK-872 | GSK583 | GSK840 | GSK-843 | HS-1371 | RIP2 kinase inhibitor 2 | PROTAC RIPK degrader-2 | RIPK-IN-4 | RIPK1-IN-4 | RIPK1-IN⁻⁷ | PROTAC RIPK degrader-6 | Kongensin A | GNE684 | cRIPGBM

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。